Melissa counsels clients in the biotechnology, biopharmaceutical, medical device and instrumentation industries on a wide range of intellectual property issues, including patent portfolio development and life cycle management, patent prosecution, and freedom-to-operate. She works with clients to develop and execute effective patent strategies focused on obtaining robust and enforceable patent protection in the United States and around the world. She also helps clients evaluate and navigate the existing patent landscape.
Melissa partners with members of the Securities and Public Companies, Life Sciences and Intellectual Property Transactions practice groups to advise clients on intellectual property issues in connection with transactions, including mergers and acquisitions, strategic partnerships, in- and out-licensing relationships, and venture financings. She evaluates the intellectual property portfolios of target companies, as well as potentially blocking third-party intellectual property, to identify strengths, weaknesses, and opportunities to create value by mitigating or remedying identified issues.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.